ACADIA Pharmaceuticals, Inc. (ACAD)
18.14
-0.23
(-1.25%)
USD |
NASDAQ |
Nov 12, 16:00
18.48
+0.34
(+1.87%)
After-Hours: 07:24
ACADIA Pharmaceuticals Total Liabilities (Quarterly) : 406.66M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 406.66M |
| June 30, 2026 | 436.29M |
| March 31, 2026 | 357.16M |
| December 31, 2025 | 336.80M |
| September 30, 2025 | 413.50M |
| June 30, 2025 | 403.17M |
| March 31, 2025 | 367.13M |
| December 31, 2024 | 454.96M |
| September 30, 2024 | 399.69M |
| June 30, 2024 | 397.40M |
| March 31, 2024 | 391.06M |
| December 31, 2023 | 317.20M |
| September 30, 2023 | 270.37M |
| June 30, 2023 | 246.98M |
| March 31, 2023 | 281.05M |
| December 31, 2022 | 187.40M |
| September 30, 2022 | 176.80M |
| June 30, 2022 | 177.92M |
| March 31, 2022 | 179.45M |
| December 31, 2021 | 159.23M |
| September 30, 2021 | 150.72M |
| June 30, 2021 | 159.59M |
| March 31, 2021 | 173.57M |
| December 31, 2020 | 155.61M |
| September 30, 2020 | 140.80M |
| Date | Value |
|---|---|
| June 30, 2020 | 96.64M |
| March 31, 2020 | 109.07M |
| December 31, 2019 | 84.05M |
| September 30, 2019 | 76.30M |
| June 30, 2019 | 71.97M |
| March 31, 2019 | 82.75M |
| December 31, 2018 | 61.12M |
| September 30, 2018 | 43.02M |
| June 30, 2018 | 50.24M |
| March 31, 2018 | 46.87M |
| December 31, 2017 | 49.22M |
| September 30, 2017 | 36.39M |
| June 30, 2017 | 41.18M |
| March 31, 2017 | 45.49M |
| December 31, 2016 | 42.74M |
| September 30, 2016 | 39.33M |
| June 30, 2016 | 29.22M |
| March 31, 2016 | 21.34M |
| December 31, 2015 | 22.13M |
| September 30, 2015 | 17.97M |
| June 30, 2015 | 19.72M |
| March 31, 2015 | 16.87M |
| December 31, 2014 | 15.97M |
| September 30, 2014 | 11.27M |
| June 30, 2014 | 9.357M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 2.519B |
| Arcturus Therapeutics Holdings, Inc. | 46.59M |
| ADMA Biologics, Inc. | 293.98M |
| Immunic, Inc. | 31.59M |
| Viking Therapeutics, Inc. | 388.57M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.794B |
| Shareholders Equity (Quarterly) | 1.387B |
| Debt to Equity Ratio | 0.0518 |
| Current Ratio | 3.818 |
| Net Debt Paydown Yield | -0.09% |